Please enable JavaScript to continue using this application.

Compare $CYDY vs $PRLD | Chartloom

Compare

$CYDY vs $PRLD

Cytodyn Inc · Prelude Therapeutics Inc

CYDY

Cytodyn Inc

PRLD

Prelude Therapeutics Inc

Compare $CYDY vs $PRLD

Comparing Cytodyn Inc and Prelude Therapeutics Inc

CYDYCytodyn Inc

PRLDPrelude Therapeutics Inc

CYDYCytodyn Inc

Market cap

$274M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-26.0%

52W performance

-24.2%

FCF yield

-6.3%

PRLDPrelude Therapeutics Inc

Market cap

$310M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.94x

Rev growth (TTM)

—

YTD performance

42.5%

52W performance

173.9%

FCF yield

-10.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CYDY

PRLD

Detailed metrics comparison

CYDY

Cytodyn Inc

PRLD

Prelude Therapeutics Inc

Market Cap

CYDY$274M

PRLD$310M

Enterprise Value

CYDY$289M

PRLD$284M

Price

CYDY$0.20

PRLD$3.89

P/E Ratio

CYDYN/A

PRLDN/A

P/S Ratio

CYDY0.00x

PRLD13.82x

EV/Sales

CYDY0.00x

PRLD12.64x

EV/EBITDA

CYDY34.72x

PRLD0.00x

P/B Ratio

CYDY106.18x

PRLD2.19x

P/FCF Ratio

CYDYN/A

PRLDN/A

EV/FCF

CYDY-16.77x

PRLD-8.53x

PEG Ratio

CYDYN/A

PRLDN/A

Forward P/E (NTM)

CYDYN/A

PRLDN/A

Forward P/S (NTM)

CYDYN/A

PRLD5.94x

Revenue (TTM)

CYDY$0

PRLD$22M

Revenue Growth (YoY)

CYDYN/A

PRLDN/A

Forward Rev Growth

CYDY0.0%

PRLD-14.3%

Gross Margin (TTM)

CYDY0.0%

PRLD0.0%

Operating Margin (TTM)

CYDY0.0%

PRLD0.0%

EBITDA Margin (TTM)

CYDY0.0%

PRLD-293.5%

Net Margin (TTM)

CYDY0.0%

PRLD-269.7%

FCF Margin (TTM)

CYDYN/A

PRLD-148.3%

Net Income (TTM)

CYDY$-44M

PRLD$-60M

FCF (TTM)

CYDY$-17M

PRLD$-33M

EPS (TTM)

CYDY-$0.03

PRLD-$0.61

ROE (TTM)

CYDY-111387.0%

PRLD-7535.0%

ROA (TTM)

CYDY-31117.0%

PRLD-4439.0%

ROIC (TTM)

CYDY-8873.0%

PRLD-7535.0%

Cash

CYDY$12M

PRLD$26M

Debt

CYDY$27M

PRLD$0

Net Cash/Debt

CYDY$-15M

PRLD$26M

Current Ratio (TTM)

CYDY0.26x

PRLD4.07x

Quick Ratio (TTM)

CYDY0.22x

PRLD3.99x

Debt/Equity (TTM)

CYDY11.55x

PRLD0.00x

Debt/Assets (TTM)

CYDY0.0%

PRLD0.0%

Interest Coverage (TTM)

CYDYN/A

PRLDN/A

Net Debt/EBITDA (TTM)

CYDY0.00x

PRLD0.00x

Beta

CYDY1.76

PRLD1.19

52W Performance

CYDY-24.2%

PRLD173.9%

YTD Performance

CYDY-26.0%

PRLD42.5%

% from 52W High

CYDY-49.6%

PRLD-43.0%

% from 52W Low

CYDY9.3%

PRLD238.3%

Asset Turnover (TTM)

CYDY0.00x

PRLD0.16x

FCF Yield (TTM)

CYDY-6.3%

PRLD-10.7%

Earnings Yield (TTM)

CYDY-16.1%

PRLD-19.5%

Dividend Yield (TTM)

CYDYN/A

PRLDN/A

Rule of 40

CYDY0.0

PRLD-148.3

EV/GP/RG

CYDYN/A

PRLDN/A

Ticker research

View CYDY research View PRLD research

Metric	CYDY Cytodyn Inc	PRLD Prelude Therapeutics Inc
Market & Valuation
Market Cap	$274M	$310M
Enterprise Value	$289M	$284M
Price	$0.20	$3.89
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.82x
EV/Sales	0.00x	12.64x
EV/EBITDA	34.72x	0.00x
P/B Ratio	106.18x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.77x	-8.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.94x
Revenue & Growth
Revenue (TTM)	$0	$22M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	-14.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-293.5%
Net Margin (TTM)	0.0%	-269.7%
FCF Margin (TTM)	N/A	-148.3%
Net Income (TTM)	$-44M	$-60M
FCF (TTM)	$-17M	$-33M
EPS (TTM)	-$0.03	-$0.61
ROE (TTM)	-111387.0%	-7535.0%
ROA (TTM)	-31117.0%	-4439.0%
ROIC (TTM)	-8873.0%	-7535.0%
Financial Health
Cash	$12M	$26M
Debt	$27M	$0
Net Cash/Debt	$-15M	$26M
Current Ratio (TTM)	0.26x	4.07x
Quick Ratio (TTM)	0.22x	3.99x
Debt/Equity (TTM)	11.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.76	1.19
52W Performance	-24.2%	173.9%
YTD Performance	-26.0%	42.5%
% from 52W High	-49.6%	-43.0%
% from 52W Low	9.3%	238.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.16x
FCF Yield (TTM)	-6.3%	-10.7%
Earnings Yield (TTM)	-16.1%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-148.3
EV/GP/RG	N/A	N/A
Ticker research	View CYDY research	View PRLD research

Valuation

P/S Ratio

CYDY

0.00x

PRLD

13.82x

EV/FCF

CYDY

-16.77x

PRLD

-8.53x

Growth & revenue

Forward Revenue Growth

CYDY

0.0%

PRLD

-14.3%

Profitability & performance

Gross Margin

CYDY

0.0%

PRLD

0.0%

ROE

PRLD

-7535.0%

CYDY

-111387.0%

FCF Yield %

CYDY

-6.3%

PRLD

-10.7%

52-Week Performance

PRLD

173.9%

CYDY

-24.2%

Detailed metrics comparison

CYDY

Cytodyn Inc

PRLD

Prelude Therapeutics Inc

Market Cap

CYDY$274M

PRLD$310M

Enterprise Value

CYDY$289M

PRLD$284M

Price

CYDY$0.20

PRLD$3.89

P/E Ratio

CYDYN/A

PRLDN/A

P/S Ratio

CYDY0.00x

PRLD13.82x

EV/Sales

CYDY0.00x

PRLD12.64x

EV/EBITDA

CYDY34.72x

PRLD0.00x

P/B Ratio

CYDY106.18x

PRLD2.19x

P/FCF Ratio

CYDYN/A

PRLDN/A

EV/FCF

CYDY-16.77x

PRLD-8.53x

PEG Ratio

CYDYN/A

PRLDN/A

Forward P/E (NTM)

CYDYN/A

PRLDN/A

Forward P/S (NTM)

CYDYN/A

PRLD5.94x

Revenue (TTM)

CYDY$0

PRLD$22M

Revenue Growth (YoY)

CYDYN/A

PRLDN/A

Forward Rev Growth

CYDY0.0%

PRLD-14.3%

Gross Margin (TTM)

CYDY0.0%

PRLD0.0%

Operating Margin (TTM)

CYDY0.0%

PRLD0.0%

EBITDA Margin (TTM)

CYDY0.0%

PRLD-293.5%

Net Margin (TTM)

CYDY0.0%

PRLD-269.7%

FCF Margin (TTM)

CYDYN/A

PRLD-148.3%

Net Income (TTM)

CYDY$-44M

PRLD$-60M

FCF (TTM)

CYDY$-17M

PRLD$-33M

EPS (TTM)

CYDY-$0.03

PRLD-$0.61

ROE (TTM)

CYDY-111387.0%

PRLD-7535.0%

ROA (TTM)

CYDY-31117.0%

PRLD-4439.0%

ROIC (TTM)

CYDY-8873.0%

PRLD-7535.0%

Cash

CYDY$12M

PRLD$26M

Debt

CYDY$27M

PRLD$0

Net Cash/Debt

CYDY$-15M

PRLD$26M

Current Ratio (TTM)

CYDY0.26x

PRLD4.07x

Quick Ratio (TTM)

CYDY0.22x

PRLD3.99x

Debt/Equity (TTM)

CYDY11.55x

PRLD0.00x

Debt/Assets (TTM)

CYDY0.0%

PRLD0.0%

Interest Coverage (TTM)

CYDYN/A

PRLDN/A

Net Debt/EBITDA (TTM)

CYDY0.00x

PRLD0.00x

Beta

CYDY1.76

PRLD1.19

52W Performance

CYDY-24.2%

PRLD173.9%

YTD Performance

CYDY-26.0%

PRLD42.5%

% from 52W High

CYDY-49.6%

PRLD-43.0%

% from 52W Low

CYDY9.3%

PRLD238.3%

Asset Turnover (TTM)

CYDY0.00x

PRLD0.16x

FCF Yield (TTM)

CYDY-6.3%

PRLD-10.7%

Earnings Yield (TTM)

CYDY-16.1%

PRLD-19.5%

Dividend Yield (TTM)

CYDYN/A

PRLDN/A

Rule of 40

CYDY0.0

PRLD-148.3

EV/GP/RG

CYDYN/A

PRLDN/A

Ticker research

View CYDY research View PRLD research

Metric	CYDY Cytodyn Inc	PRLD Prelude Therapeutics Inc
Market & Valuation
Market Cap	$274M	$310M
Enterprise Value	$289M	$284M
Price	$0.20	$3.89
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.82x
EV/Sales	0.00x	12.64x
EV/EBITDA	34.72x	0.00x
P/B Ratio	106.18x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.77x	-8.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.94x
Revenue & Growth
Revenue (TTM)	$0	$22M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	-14.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-293.5%
Net Margin (TTM)	0.0%	-269.7%
FCF Margin (TTM)	N/A	-148.3%
Net Income (TTM)	$-44M	$-60M
FCF (TTM)	$-17M	$-33M
EPS (TTM)	-$0.03	-$0.61
ROE (TTM)	-111387.0%	-7535.0%
ROA (TTM)	-31117.0%	-4439.0%
ROIC (TTM)	-8873.0%	-7535.0%
Financial Health
Cash	$12M	$26M
Debt	$27M	$0
Net Cash/Debt	$-15M	$26M
Current Ratio (TTM)	0.26x	4.07x
Quick Ratio (TTM)	0.22x	3.99x
Debt/Equity (TTM)	11.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.76	1.19
52W Performance	-24.2%	173.9%
YTD Performance	-26.0%	42.5%
% from 52W High	-49.6%	-43.0%
% from 52W Low	9.3%	238.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.16x
FCF Yield (TTM)	-6.3%	-10.7%
Earnings Yield (TTM)	-16.1%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-148.3
EV/GP/RG	N/A	N/A
Ticker research	View CYDY research	View PRLD research